Related references
Note: Only part of the references are listed.The mixture of ecstasy and its metabolites is toxic to human SH-SY5Y differentiated cells at in vivo relevant concentrations
Daniel Jose Barbosa et al.
ARCHIVES OF TOXICOLOGY (2014)
Neurotoxicity of ecstasy and its metabolites in human dopaminergic differentiated SH-SY5Y cells
Patricia Silva Ferreira et al.
TOXICOLOGY LETTERS (2013)
Toxicity of amphetamines: an update
Marcia Carvalho et al.
ARCHIVES OF TOXICOLOGY (2012)
Pro-oxidant effects of Ecstasy and its metabolites in mouse brain synaptosomes
J. Barbosa et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
MDMA and 5-HT neurotoxicity: the empirical evidence for its adverse effects in humans - no need for translation
Andrew C. Parrott
BRITISH JOURNAL OF PHARMACOLOGY (2012)
In Vivo Imaging of Cerebral Serotonin Transporter and Serotonin2A Receptor Binding in 3,4-Methylenedioxymethamphetamine (MDMA or Ecstasy) and Hallucinogen Users
David Erritzoe et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA
Noelia Granado et al.
NEUROBIOLOGY OF DISEASE (2011)
Persistent Nigrostriatal Dopaminergic Abnormalities in Ex-Users of MDMA ('Ecstasy'): An 18F-Dopa PET Study
Yen F. Tai et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[11C]DASB and structural brain imaging study
Stephen J. Kish et al.
BRAIN (2010)
The role of monoamines in the changes in body temperature induced by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its derivatives
J. R. Docherty et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Synthesis and in Vitro Cytotoxicity Profile of the R-Enantiomer of 3,4-Dihydroxymethamphetamine (R-(-)-HHMA): Comparison with Related Catecholamines
Anne Felim et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2010)
Chronic Stress Enhances the Corticosterone Response and Neurotoxicity to +3,4-Methylenedioxymethamphetamine (MDMA): The Role of Ambient Temperature
Bethann N. Johnson et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Low striatal serotonin transporter protein in a human polydrug MDMA (ecstasy) user: a case study
S. J. Kish et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
THC Prevents MDMA Neurotoxicity in Mice
Clara Tourino et al.
PLOS ONE (2010)
Learning and memory deficits in ecstasy users and their neural correlates during a face-learning task
Gloria M. P. Roberts et al.
BRAIN RESEARCH (2009)
Metabolites of MDMA Induce Oxidative Stress and Contractile Dysfunction in Adult Rat Left Ventricular Myocytes
Sylvia K. Shenouda et al.
CARDIOVASCULAR TOXICOLOGY (2009)
Nicotinic Receptor Stimulation Protects Nigral Dopaminergic Neurons in Rotenone-induced Parkinson's Disease Models
Hiroki Takeuchi et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2009)
Plasma membrane glutathione transporters and their roles in cell physiology and pathophysiology
Nazzareno Ballatori et al.
MOLECULAR ASPECTS OF MEDICINE (2009)
Molecular and Cellular Mechanisms of Ecstasy-Induced Neurotoxicity: An Overview
Joao Paulo Capela et al.
MOLECULAR NEUROBIOLOGY (2009)
Modulation of human multidrug resistance protein (MRP) 1 (ABCC1) and MRP2 (ABCC2) transport activities by endogenous and exogenous glutathione-conjugated catechol metabolites
Andrew J. Slot et al.
DRUG METABOLISM AND DISPOSITION (2008)
Accumulation of neurotoxic thioether metabolites of 3,4-(+/-)-methylenedioxymethamphetamine in rat brain
Gladys V. Erives et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Evaluation of GSH adducts of adrenaline in biological samples
Renata Silva et al.
BIOMEDICAL CHROMATOGRAPHY (2007)
Neurotoxicity mechanisms of thioether ecstasy metabolites
J. P. Capela et al.
NEUROSCIENCE (2007)
Upregulation of γ-glutamate-cysteine ligase as part of the long-term adaptation process to iron accumulation in neuronal SH-SY5Y cells
Pabla Aguirre et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Synthesis and cyclic voltammetry studies of 3,4-methylenedioxymethamphetamine (MDMA) human metabolites
Carla Macedo et al.
JOURNAL OF HEALTH SCIENCE (2007)
Damage of serotonergic axons and immunolocalization of Hsp27, Hsp72, and Hsp90 molecular chaperones after a single dose of MDMA administration in Dark Agouti rat:: Temporal, spatial, and cellular patterns
Csaba Adori et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2006)
Memory deficits in abstinent MDMA (ecstasy) users:: neuropsychological evidence of frontal dysfunction
Boris B. Quednow et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2006)
Neurotoxicity of ecstasy metabolites in rat cortical neurons, and influence of hyperthermia
JP Capela et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Ecstasy-induced cell death in cortical neuronal cultures is serotonin 2A-receptor-dependent and potentiated under hyperthermia
J. P. Capela et al.
NEUROSCIENCE (2006)
A comparative study on the acute and long-term effects of MDMA and 3,4-dihydroxymethamphetamine (HHMA) on brain monoamine levels after i.p. or striatal administration in mice
I Escobedo et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Serotonergic neurotoxic metabolites of ecstasy identified in rat brain
DC Jones et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Metabolism is required for the expression of ecstasy-induced cardiotoxicity in vitro
M Carvalho et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2004)
The role of metabolism in 3,4-(±)-methylenedioxyamphetamine and 3.4-(±)-methylenedioxymethamphetamine (ecstasy) toxicity
TJ Monks et al.
THERAPEUTIC DRUG MONITORING (2004)
Neurotoxicity of MDMA (ecstasy):: the limitations of scaling from animals to humans
R de la Torre et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
The toxicity of N-methyl-α-methyldopamine to freshly isolated rat hepatocytes is prevented by ascorbic acid and N-acetylcysteine
M Carvalho et al.
TOXICOLOGY (2004)
Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists
SP Presgraves et al.
NEUROTOXICITY RESEARCH (2004)
Progressive iron accumulation induces a biphasic change in the glutathione content of neuroblastoma cells
MT Nuñez et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)
AR Green et al.
PHARMACOLOGICAL REVIEWS (2003)
Demonstration and localization of neuronal degeneration in the rat forebrain following a single exposure to MDMA
LC Schmued
BRAIN RESEARCH (2003)
Role of metabolites in MDMA (ecstasy)-induced nephrotoxicity: an in vitro study using rat and human renal proximal tubular cells
M Carvalho et al.
ARCHIVES OF TOXICOLOGY (2002)
Serotonergic neurotoxicity of 3,4-(±) -methylenedioxyamphetamine and 3,4-(±)-methylendioxymethamphetamine (ecstasy) is potentiated by inhibition of γ-glutamyl transpeptidase
FJ Bai et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2001)
3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected nenrotoxic dose
B Esteban et al.
PSYCHOPHARMACOLOGY (2001)
Is hyperthermia the triggering factor for hepatotoxicity induced by 3,4-methylenedioxymethamphetamine (ecstasy)? An in vitro study using freshly isolated mouse hepatocytes
M Carvalho et al.
ARCHIVES OF TOXICOLOGY (2001)
Share Paper
